On the antiatherogenic effects of vitamin E: the search for the Holy Grail.
作者信息
Galli Francesco
出版信息
Vasc Health Risk Manag. 2010 Mar 3;6:69-71; author reply 71. doi: 10.2147/vhrm.s9289.
Abstract
摘要
相似文献
1
On the antiatherogenic effects of vitamin E: the search for the Holy Grail.
Vasc Health Risk Manag. 2010 Mar 3;6:69-71; author reply 71. doi: 10.2147/vhrm.s9289.
2
Vitamin E, 5-lipoxygenase and oxidative stress in haemodialysis patients: facts, not fancies.
Nephrol Dial Transplant. 2008 Feb;23(2):772-3. doi: 10.1093/ndt/gfm770. Epub 2007 Oct 28.
3
Antiatherogenic effects of vitamin E: the search for the Holy Grail.
Vasc Health Risk Manag. 2009;5:767-74. doi: 10.2147/vhrm.s5532. Epub 2009 Sep 18.
4
Treatment with Vitamin E-coated membrane dialysers and cardiovascular protection in dialysis patients.
Nephrol Dial Transplant. 2011 May;26(5):1754; author reply 1754-5. doi: 10.1093/ndt/gfr028. Epub 2011 Mar 29.
5
Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations.
J Cardiovasc Pharmacol Ther. 2007 Dec;12(4):265-82. doi: 10.1177/1074248407299519.
6
The impact of vitamin E-coated membranes on soluble adhesion molecules.
Nephrol Dial Transplant. 2011 Jul;26(7):2416; author reply 2416-7. doi: 10.1093/ndt/gfr228. Epub 2011 May 12.
7
Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells.
Kidney Int. 2003 May;63(5):1881-7. doi: 10.1046/j.1523-1755.2003.00920.x.
8
The effect of vitamin E-coated membrane dialysers on inflammation and oxidative stress in maintenance haemodialysis patients.
Nephrol Dial Transplant. 2011 Sep;26(9):3064-5; author reply 3065. doi: 10.1093/ndt/gfr329. Epub 2011 Jul 12.
9
Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.
Kidney Blood Press Res. 2003;26(3):185-91. doi: 10.1159/000071884.
10
The effect of vitamin E-bonded dialyzer membrane on red blood cell survival in hemodialyzed patients.
Artif Organs. 2003 Mar;27(3):214-7. doi: 10.1046/j.1525-1594.2003.07214.x.
引用本文的文献
1
Evaluation of the impact of a new synthetic vitamin E-bonded membrane on anemia and rHuEPO requirement in ESRD patients with central venous catheters: a pilot study.
Int Urol Nephrol. 2012 Oct;44(5):1493-500. doi: 10.1007/s11255-011-0016-9. Epub 2011 Sep 29.
本文引用的文献
1
Present trends in vitamin E research.
Biofactors. 2010 Jan-Feb;36(1):33-42. doi: 10.1002/biof.75.
2
Antiatherogenic effects of vitamin E: the search for the Holy Grail.
Vasc Health Risk Manag. 2009;5:767-74. doi: 10.2147/vhrm.s5532. Epub 2009 Sep 18.
3
Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers.
Acta Biomater. 2009 Oct;5(8):2974-82. doi: 10.1016/j.actbio.2009.04.011. Epub 2009 May 4.
4
Vitamin E biotransformation in humans.
Vitam Horm. 2007;76:263-80. doi: 10.1016/S0083-6729(07)76009-0.
5
A systematic review of the effect of the Excebrane dialyser on biomarkers of lipid peroxidation.
Nephrol Dial Transplant. 2006 Oct;21(10):2825-33. doi: 10.1093/ndt/gfl376. Epub 2006 Jul 22.
6
Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
Nephrol Dial Transplant. 2005 Dec;20(12):2775-82. doi: 10.1093/ndt/gfi121. Epub 2005 Oct 12.
7
Vitamin E in uremia and dialysis patients.
Ann N Y Acad Sci. 2004 Dec;1031:348-51. doi: 10.1196/annals.1331.041.
8
Vitamin E-coated dialyzer membranes downregulate expression of monocyte adhesion and co-stimulatory molecules.
Blood Purif. 2004;22(6):510-7. doi: 10.1159/000082042. Epub 2004 Nov 10.
9
Von Willebrand factor and autoantibodies against oxidized LDL in hemodialysis patients treated with vitamin E-modified dialyzers.
Int J Artif Organs. 2004 Mar;27(3):214-21. doi: 10.1177/039139880402700308.
10
Accumulation of vitamin E metabolites in the blood of renal failure patients.
Clin Nutr. 2004 Apr;23(2):205-12. doi: 10.1016/S0261-5614(03)00128-6.
Zotero 插件